Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin

Published:2014-03 Issue:3 Volume:16 Page:137-144
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Mudaliar Sunder¹,Henry Robert R.¹,Boden Guenther²,Smith Steven³,Chalamandaris Alexandros-Georgios⁴,Duchesne Dominique⁵,Iqbal Nayyar⁵,List James⁵

Affiliation:

1. Center for Metabolic Research, VA San Diego Healthcare System, and University of California, San Diego, San Diego, California.

2. School of Medicine, Temple University, Philadelphia, Pennsylvania.

3. Florida Hospital, Orlando, Florida.

4. Bristol-Myers Squibb, Braine-l'Alleud, Belgium.

5. Bristol-Myers Squibb, Princeton, New Jersey.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2013.0167

Reference18 articles.

1. Pathogenesis of type 2 diabetes mellitus

2. Abnormalities in insulin secretion in type 2 diabetes mellitus

3. Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies

4. Glucotoxicity and β-Cell Failure in Type 2 Diabetes Mellitus

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials;Expert Opinion on Pharmacotherapy;2024-05-02

2. The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver disease; a narrative review;Journal of Mind and Medical Sciences;2024-04-30

3. Comparative analysis of newer classes of antidiabetics and the concept of pharmaceutical care – dealing with therapeutic problems;Pharmacia;2024-02-22

4. Sodium–Glucose Cotransporter Protein 2 Inhibitors: Novel Application for the Treatment of Obesity-Associated Hypertension;Diabetes, Metabolic Syndrome and Obesity;2024-01

5. SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus;Current Medicinal Chemistry;2023-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3